By Vimal Aga MD (bio) and Rajnish Mago MD (bio) This article was first published on September 13, 2023. It was last reviewed, updated, or edited on September 15, 2023. “Disease-modifying treatments” for Alzheimer’s disease that have been approved by the United States Food and Drug Administration (FDA) include: – Aducanumab (brand name Aduhelm®) – Lecanemab…